%%tb-image-alt-text%%

Are you a healthy female aged between 25 to 50 years? Join a patch clinical trial and help patients with multiple sclerosis.

Scientia Clinical trial is seeking participants to join a clinical trial. The clinical trial involves wearing a patch for one week. Participants will need to be available for 10 days …

CONDITION: Other

GENDER: Females

AGE GROUP: 25 to 50 years

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Healthy Caucasian Males Needed for a Clinical Trial!

We are testing a treatment developed for polycythemia vera, which is a condition that has limited therapeutic options and no cure is currently available. The medication will be administered subcutaneously …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 50 years

TRIAL STATUS: Completed

%%tb-image-alt-text%%

NOX66 and Palliative Radiotherapy in Patients with Late-Stage Prostate Cancer

The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …

CONDITION: Cancer

GENDER: Males

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Facial Acne Medication Study

Adults and Children ages 9+ may qualify for a study of an investigational facial acne medication. To participate you must: Have at least 20 red irritated pimples and at least …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 9 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Do you have Asthma?

Australian researchers are trialing a potential new treatment for Asthma. They are looking for volunteers to take part in the Australian arm of a worldwide study. This study will be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 to 100 years

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Weekend Study

20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 45 years

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Atopic Dermatitis

This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

Mild To Moderate Plaque Psoriasis

AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

COPD – FLASH STUDY – Multi-centre

Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

CHRONIC PAIN – Survey Assessment

people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

%%tb-image-alt-text%%

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed